p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: One-year follow-up

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

397

HTML

3518

Figures (1-3)

135

Tables (1-5)

138

Sum=4188

Apr 28, 2011 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2011; 17(16): 2143-2149
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2143

Table 5 Therapeutic effect evaluated following response evaluation criteria for solid tumors 2 mo after treatment

χ² = 4.137, P = 0.042 < 0.05. CR: Complete response; PR: Partial response; NC: No change; PD: Progressed disease.

Citation: Guan YS, Liu Y, He Q, Li X, Yang L, Hu Y, La Z. p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: One-year follow-up. World J Gastroenterol 2011; 17(16): 2143-2149
URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2143.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i16.2143